Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Ovarian Neoplasms and MTOR[original query] |
|---|
| PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors. Molecular cancer therapeutics 2011 Mar 10 (3): 558-65. Janku Filip, Tsimberidou Apostolia M, Garrido-Laguna Ignacio, Wang Xuemei, Luthra Rajyalakshmi, Hong David S, Naing Aung, Falchook Gerald S, Moroney John W, Piha-Paul Sarina A, Wheler Jennifer J, Moulder Stacy L, Fu Siqing, Kurzrock Razel |
| PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Mar 30 (8): 777-82. Janku Filip, Wheler Jennifer J, Westin Shannon N, Moulder Stacy L, Naing Aung, Tsimberidou Apostolia M, Fu Siqing, Falchook Gerald S, Hong David S, Garrido-Laguna Ignacio, Luthra Rajyalakshmi, Lee J Jack, Lu Karen H, Kurzrock Razel |
| Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway. Oncotarget 2014 May 5 (10): 3029-38. Wheler Jennifer J, Moulder Stacy L, Naing Aung, Janku Filip, Piha-Paul Sarina A, Falchook Gerald S, Zinner Ralph, Tsimberidou Apostolia M, Fu Siqing, Hong David S, Atkins Johnique T, Yelensky Roman, Stephens Philip J, Kurzrock Razel |
| Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer. Journal of molecular medicine (Berlin, Germany) 2016 Feb . Er Tze-Kiong, Su Yu-Fa, Wu Chun-Chieh, Chen Chih-Chieh, Wang Jing, Hsieh Tsung-Hua, Herreros-Villanueva Marta, Chen Wan-Tzu, Chen Yi-Ting, Liu Ta-Chih, Chen Hung-Sheng, Tsai Eing-M |
| A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors. Investigational new drugs 2016 Dec . Kyriakopoulos Christos E, Braden Amy M, Kolesar Jill M, Eickhoff Jens C, Bailey Howard H, Heideman Jennifer, Liu Glenn, Wisinski Kari |
| MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance. Journal of cancer research and clinical oncology 2018 8 144 (12): 2313-2318. Gasparri Maria Luisa, Besharat Zein Mersini, Farooqi Ammad Ahmad, Khalid Sumbul, Taghavi Katayoun, Besharat Raad Aris, Sabato Claudia, Papadia Andrea, Panici Pierluigi Benedetti, Mueller Michael David, Ferretti Elisabet |
| Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883). Journal of medical genetics 2019 4 56 (9): 574-580. Hauke Jan, Hahnen Eric, Schneider Stephanie, Reuss Alexander, Richters Lisa, Kommoss Stefan, Heimbach André, Marmé Frederik, Schmidt Sandra, Prieske Katharina, Gevensleben Heidrun, Burges Alexander, Borde Julika, De Gregorio Nikolaus, Nürnberg Peter, El-Balat Ahmed, Thiele Holger, Hilpert Felix, Altmüller Janine, Meier Werner, Dietrich Dimo, Kimmig Rainer, Schoemig-Markiefka Birgid, Kast Karin, Braicu Elena, Baumann Klaus, Jackisch Christian, Park-Simon Tjoung-Won, Ernst Corinna, Hanker Lars, Pfisterer Jacobus, Schnelzer Andreas, du Bois Andreas, Schmutzler Rita K, Harter Phili |
| Prevalence of pathogenic variants in actionable genes in advanced ovarian cancer: a next-generation sequencing analysis of a nationwide registry study. European journal of cancer (Oxford, England : 1990) 2020 11 141 185-192. Kang Sokbom, Yu Ye L, Cho Soo Y, Park Seog-Y |
| Genetically predicted circulating protein biomarkers and ovarian cancer risk. Gynecologic oncology 2020 Nov . Considine Daniel P C, Jia Guochong, Shu Xiang, Schildkraut Joellen M, Pharoah Paul D P, Zheng Wei, Kar Siddhartha P, |
| Genetic alterations and their therapeutic implications in epithelial ovarian cancer. BMC cancer 2021 5 21 (1): 499. Lapke Nina, Chen Chien-Hung, Chang Ting-Chang, Chao Angel, Lu Yen-Jung, Lai Chyong-Huey, Tan Kien Thiam, Chen Hua-Chien, Lu Hsiao-Yun, Chen Shu-J |
| Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2022 11 32 (12): 1568-1575. van Bommel Majke H D, Pijnenborg Johanna M A, van der Putten Louis J M, Bulten Johan, Snijders Marc P L M, Küsters-Vandevelde Heidi V N, Sweegers Sanne, Vos M Caroline, Ligtenberg Marjolein J L, Eijkelenboom Astrid, de Hullu Joanne A, Reijnen Casp |
| Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma. British journal of cancer 2022 Jan . Ye Shuang, Li Qin, Wu Yutuan, Jiang Wei, Zhou Shuling, Zhou Xiaoyan, Yang Wentao, Tu Xiaoyu, Shan Boer, Huang Shenglin, Yang Huiju |
| Aberrant serum and tissue levels of Beclin1 and mechanistic target of rapamycin (mTOR) proteins in epithelial ovarian cancer. Medicine 2023 4 102 (17): e33515. Huixia Lu, Hong Hu, Zhihong Yang, Shaobo |
| Case report: Response to everolimus in a patient with platinum resistant, high grade serous ovarian carcinoma with biallelic TSC2 inactivation. Frontiers in oncology 2024 4 14 1357980. Mariko Peterson, David L Kolin, Panagiotis A Konstantinopoul |
- Page last reviewed:Feb 1, 2024
- Content source: